The Analyst Verdict: Edgewell Personal Care In The Eyes Of 7 Experts
In the last three months, 7 analysts have published ratings on Edgewell Personal Care (NYSE:EPC), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $21.29, along with a high estimate of $23.00 and a low estimate of $19.00. Experiencing a 5.67% decline, the current average is now lower than the previous average price target of $22.57.
Decoding Analyst Ratings: A Detailed Look
An in-depth analysis of recent analyst actions unveils how financial experts perceive Edgewell Personal Care. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $21.00 | $19.00 |
| Chris Carey | Wells Fargo | Raises | Overweight | $22.00 | $20.00 |
| Chris Carey | Wells Fargo | Lowers | Overweight | $20.00 | $23.00 |
| Dara Mohsenian | Morgan Stanley | Lowers | Equal-Weight | $21.00 | $23.00 |
| Lauren Lieberman | Barclays | Lowers | Equal-Weight | $19.00 | $22.00 |
| Nik Modi | RBC Capital | Lowers | Outperform | $23.00 | $26.00 |
| Chris Carey | Wells Fargo | Lowers | Overweight | $23.00 | $25.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Edgewell Personal Care. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Edgewell Personal Care compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Edgewell Personal Care's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Edgewell Personal Care's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Edgewell Personal Care analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Unveiling the Story Behind Edgewell Personal Care
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. Sun and Skin Care consists of sun care products, men's and women's grooming products, Billie women's grooming products and personal wipe products. Feminine Care products include tampons, pads and liners. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
Unraveling the Financial Story of Edgewell Personal Care
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Edgewell Personal Care's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.79% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -5.7%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Edgewell Personal Care's ROE excels beyond industry benchmarks, reaching -1.96%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Edgewell Personal Care's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.81%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.91.
Understanding the Relevance of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.